News

SARS-CoV-2 uses a surface spike protein to latch onto human cells and initiate infection. But, the drug heparin is capable of binding tightly to the same surface spike protein, potentially blocking the infection from happening.

Cold Spring Harbor Laboratory (CSHL) Associate Professor Mikala Egeblad and her colleagues describe a newly understood way by which breast cancer cells sabotage a key player in the body’s immune system.

Biomolecular engineers have uncovered a technique that dramatically enhances the accuracy of CRISPR-based edits in disease sequence models.

In Phase 2b clinical trials, a once-daily roflumilast cream showed significant improvements in psoriasis signs and symptoms, in as early as two weeks.

A study published in Nature Communications presented evidence of transplacental transmission of SARS-CoV-2 from an infected mother to her unborn child.

A single protein derived from a common strain of bacteria found in the soil will offer scientists a more precise way to edit RNA.

Researchers have found that placental cells minimally express the instructions, or mRNA, to generate the cell entry receptor and protease required by the virus that causes COVID-19 to invade human cells.

Pharmacists at Martin Luther University Halle-Wittenberg have succeeded in detecting small amounts of SARS-CoV-2 using mass spectrometry and gargle solutions of COVID-19 patients.

Researchers quantified the forces that cause critical damage on a single E. coli bacterium under physiological conditions using AFM nanoindentation and fluorescence imaging.

Using single nucleus sequencing technologies in human heart samples, researchers have established a potential mechanism for cardiac complications related to COVID-19.